The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: -0.17 (-5.57%)
Spread: 0.10 (3.448%)
Open: 3.05
High: 2.88
Low: 2.88
Prev. Close: 3.05
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

Wed, 28th Apr 2021 15:30

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Deliveroo PLC - London-based takeaway food delivery service - Hires Dominique Reiniche and Karen Jones as non-executive directors. Reiniche was president and then chair of the Europe Group of Coca-Cola Co. She is a non-executive director of packaging firm Mondi PLC and currently a non-executive director of Severn Trent PLC, though is set to step down from the water utility's board. Reiniche also is chair of Eurostar. Jones was founder of restaurant chain Cafe Rouge and currently is chair of steak house Hawskmoor and executive chair of pasta house Prezzo.

----------

FIH Group PLC - provider of retail, transport and logistics services in UK and Falkland Islands - Hires Stuart Munro as chief financial officer, starting Wednesday. Munro has worked as a finance director in infrastructure and transport firms such as Balfour Beatty PLC, Alfred McAlpine Infrastructure Services, FirstGroup PLC and Transport for London.

----------

Wickes Group PLC - United Utilities Group PLC, Grainger PLC and Aggreko PLC note that Mark Clare, a non-executive director for all three, has been appointed as senior independent non-executive director of Wickes, as the spin-off from Travis Perkins PLC starts trading on London Main Market on Wednesday. Pets At Home Group PLC notes that Chief Financial Officer Mike Iddon is a non-executive director of Wickes.

----------

Tate & Lyle PLC - Hires Patricia Corsi as non-executive director, starting May 1. Corsi is global chief marketing & digital officer for Bayer Consumer Health, part of Bayer AG. Previously she worked for brewer Heineken NV and consumer goods firms Unilever PLC and Kraft Foods, part of Kraft Heinz Co. As previously announced, Anne Minto will retire at the July 29 annual general meeting.

----------

Redcentric PLC - Harrogate, North Yorkshire-based IT managed services - Non-Executive Director Steve Vaughan steps down from board, effective immediately, "to focus on other interests". Redcentric says it has started a review of board composition.

----------

Boston International Holdings PLC - special purpose acquisitions company - Hires Christopher Pitman as chair and Martin Lampshire as non-executive director, effective immediately. Pitman is a petroleum geologist with 35 years exploration and production experience, BIH says, while Lampshire is a broker who is executive director of Global Resources Investment Trust PLC and non-executive director of Bould Opportunities PLC and ValiRx PLC. BIH also says it is delaying its 2020 accounts to no later than June 30.

----------

AFC Energy PLC - Surrey-based hydrogen power generation technology - Hires David Harvey as chief technology officer, starting in May. Harvey was senior research engineer at Ballard Power Systems and head of Fuel Cell Development at Fuel Cell Powertrain GmbH. He is relocating to the UK to take the job.

----------

B90 Holdings PLC - Isle of Man-based sportsbook operator and online marketing gaming - Rainer Lauffs to step down as chief operating officer and from board in six months time, following a handover. Ronny Breivik is hired to be CEO of main operating subsidiary B90 Ventures Ltd, joining initially as a consultant. Brievik has worked in online gaming since 1997 and launched the first gaming portal in Norway, B90 says. Brievik will be issued 280,000 shares as his initial fee, followed by a further 280,000 on June 30. B90 was quoted at 13.00 pence on Wednesday afternoon, making the 560,000 shares worth GBP72,800.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

Read more
29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

Read more
27 May 2020 14:20

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

Read more
7 May 2020 14:45

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

Read more
4 May 2020 16:18

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

Read more
4 May 2020 16:10

ValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out

ValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out

Read more
4 May 2020 14:26

ValiRx shores up capital position with ?1.17m fundraise

(Sharecast News) - Clinical-stage biotechnology company ValiRx announced a conditional fundraise through the conditional issue of 18,069,467 new ordinary shares on Monday, to raise ?1.17m.

Read more
1 May 2020 14:57

UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO

UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO

Read more
1 May 2020 14:33

ValiRx signs VAL301 deal with Japanese firm

(Sharecast News) - Clinical-stage biotechnology company ValiRx has signed an agreement with an unnamed global Japanese pharmaceutical company to evaluate its therapeutic, VAL301, in order to contemplate a potential future license for its use in the treatment of endometriosis.

Read more
1 May 2020 14:23

ValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm

ValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm

Read more
1 May 2020 10:42

UK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking

UK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking

Read more
29 Apr 2020 18:19

ValiRx Confirms JV Talks For Non-Core Intellectual Property

ValiRx Confirms JV Talks For Non-Core Intellectual Property

Read more
14 Apr 2020 14:51

UK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost

UK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost

Read more
7 Apr 2020 16:10

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Apr 2020 13:57

ValiRx raises ?0.2m through placing with new investors

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Wednesday that it has conditionally raised ?0.2m gross through the issue of 5,714,288 new ordinary shares at a post-reorganisation price of 3.5p each, with new investors.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.